NeoGenomics, Inc. Current Assets
NeoGenomics, Inc. (NEO) had Current Assets of $381.48 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-28
- 2026-06-30: Assets, Current $381.48M.
- 2026-03-31: Assets, Current $373.68M.
- 2025-12-31: Assets, Current $376.29M.
- 2025-09-30: Assets, Current $382.46M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $381.48M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $373.68M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $376.29M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $382.46M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $392.55M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $573.93M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $596.02M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $590.24M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $584.20M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $573.90M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $596.81M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $586.95M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $584.72M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $585.00M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $605.29M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $603.36M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $622.26M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $651.10M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $681.51M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $709.93M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $721.79M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $942.73M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $448.73M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $422.38M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $419.00M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $215.44M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $290.74M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $292.00M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $276.35M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $115.94M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $103.67M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $194.27M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $83.26M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $87.77M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $85.88M 10-K · filed 2019-02-26 | $84.96M 10-K · filed 2018-03-13 |
| 2017-09-30 | $85.75M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $83.36M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $84.58M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $78.83M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $92.56M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $87.51M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $81.20M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $82.36M 10-K · filed 2017-03-14 | $99.03M 10-K · filed 2016-03-15 |
| 2015-09-30 | $60.86M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $59.60M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $57.33M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $58.74M 10-K · filed 2016-04-18 | |
| 2014-09-30 | $57.24M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $28.08M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $28.15M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $27.49M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $23.83M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $23.16M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $22.74M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $18.58M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $17.12M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $16.56M 10-Q/A · filed 2012-08-15 | |
| 2012-03-31 | $15.99M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $13.18M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $12.31M 10-Q · filed 2011-10-25 | |
| 2011-06-30 | $12.02M 10-Q/A · filed 2011-08-01 | |
| 2010-12-31 | $8.74M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |